Virios

VIRI

VIRI Virios NASDAQ
Add to watchlist
--
At close :
--
  • Post market
    • Summary
    Financials
    News
    Filings
    Profile
    VIRI Chart
    See on advanced chart >

    About

    Virios Therapeutics, Inc. is a development-stage biotechnology company focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, such as fibromyalgia (“FM”).
    Read More
    • Highlight
      A development-stage biotechnology company that develops novel antiviral therapies for fibromyalgia and other diseases
      • Industry
      Biotechnology
    • Exchange
      NASDAQ
    • Listing Date
      12/17/2020
    • Established Date
      Invalid Date
    • Full-time Employees
      4
    • Address
      44 Milton Avenue Alpharetta GA 30009
    • Tel
      1-866-6208655
    • Website
      www.virios.com
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock